Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances
about
A new generation of human artificial chromosomes for functional genomics and gene therapyA pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challengesUtrophin up-regulation by an artificial transcription factor in transgenic miceFunctional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout miceEfficient in vitro gene delivery by hybrid biopolymer/virus nanobiovectorsTargeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy.Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex.Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.Systemic RNAi delivery to the muscles of ROSA26 mice reduces lacZ expressionHuman artificial chromosomes for gene delivery and the development of animal modelsAAV-microdystrophin therapy improves cardiac performance in aged female mdx mice.β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx miceApproaching a new age in Duchenne muscular dystrophy treatment.Design of hybrid lipid/retroviral-like particle gene delivery vectors.Stem cells and plasticity of skeletal muscle cell differentiation: potential application to cell therapy for degenerative muscular diseases.Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophyRe-engineering an alphoid(tetO)-HAC-based vector to enable high-throughput analyses of gene function.Emerging strategies for cell and gene therapy of the muscular dystrophiesImplications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle.Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin.Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice.Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type miceSkeletal muscle as a paradigm for regenerative biology and medicine.Gene therapy for muscular dystrophy: current progress and future prospects.Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophyPreclinical studies for gene therapy of Duchenne muscular dystrophy.Current advances in cell therapy strategies for muscular dystrophies.Human artificial chromosome-based gene delivery vectors for biomedicine and biotechnology.Invited review: Stem cells and muscle diseases: advances in cell therapy strategies.PhiC31 integrase-mediated genomic integration and stable gene expression in the mouse mammary gland after gene electrotransfer.Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophyMild Aerobic Exercise Training Hardly Affects the Diaphragm of mdx Mice.Complete genetic correction of ips cells from Duchenne muscular dystrophy.DYS-HAC-iPS cells: the combination of gene and cell therapy to treat duchenne muscular dystrophy.Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES.Correction of a genetic defect in multipotent germline stem cells using a human artificial chromosome.Reduction in mdx mouse muscle degeneration by low-intensity endurance exercise: a proteomic analysis in quadriceps muscle of exercised compared with sedentary mdx mice.Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin.Cellular Transplantation Alters the Disease Progression in Becker's Muscular Dystrophy.
P2860
Q24599954-A39B89B5-E258-4A04-A452-6DA514DE7840Q26824073-1D44945A-827D-496F-9EA9-05B0E79E352EQ28469278-F3917331-34EC-4D1C-BC84-5C38F1E8B28AQ33375717-89380620-807B-499E-9DAD-6DA1577DDC3AQ34216718-588CDF34-B389-4D44-AEF7-7A38A32EFF5DQ34756106-AE8D7B8B-75F3-4614-9A4D-BAE5D183218BQ34871548-F47337BC-19E7-46CA-BF17-2DDC9A3FB5B5Q34994545-A6D4B7D3-76C3-4322-B99A-E89366FE8BC0Q35225707-5EF734D5-CB1F-4A86-9A3A-5306FDBD8A8CQ35238272-0F568352-965E-49C5-AD72-B5111682D475Q35285784-C2F889CB-CEDD-4EB4-B3E2-DD58A9E47E65Q35817497-00B99515-EF6E-43AB-9106-03E0CEC90C32Q35888398-2C2E0952-5DCB-4E9F-BE5E-495DF0288A40Q36823864-B02B54DA-58B3-4A73-B963-739EE29058F2Q36825858-1365E6B8-6F6E-4E4D-ADD5-422A376EBF4BQ36841572-30C9ED85-7A5D-4CBB-9892-46153F473824Q36878392-B6C471CB-A8B2-49CE-8B38-271567B98881Q36960845-A7B8FF51-6B70-4274-90A1-FFCF0403D94DQ37063632-4A51A3ED-C532-4515-A361-0599D80688F8Q37090043-51AE8524-4FFA-4027-B0DF-E7B5D7F225E7Q37102146-5B468728-DE04-48E3-B2E6-B5E7E681D086Q37116446-DBD78400-521E-401F-9679-9A9308806198Q37139061-3E40882C-EAE7-44E7-99FD-13D25D25CED5Q37422514-42ECCC83-D2B0-4BCB-BF14-CBE365D3EA9BQ37519650-CF0A99D1-DA29-4AC3-9640-A2F0D5883F59Q37560090-85156E63-8616-4F7F-92C0-2411939C308DQ37760380-397B4A4A-AAF7-4536-B7FF-88764E3D200FQ37827157-C3D385DF-96E7-4285-936A-137EE55C90CCQ38183464-5D67359D-3279-446C-8A72-70AB34D93C3BQ38269131-ECA3E1B5-72D3-4563-87AE-65C52FA3A749Q39052129-264B901C-1A22-4571-A20B-2C9D75031851Q39410461-39AC331C-229E-4426-A1A7-7D96E95DC54FQ39439963-F9643469-2707-47DF-8F31-DA21C2CA84EFQ39641162-417FE052-20B1-4105-A08B-B5768EA1FA61Q39641618-2554EC05-AF1B-4441-A800-5F81EE36ABC0Q39998139-22112A3C-5617-4B78-A35A-13EA74131A21Q40119475-708590E7-3936-4D5D-90A3-446B3879A686Q40728538-FE62BE16-9951-44B0-B336-A0D34E83A036Q41951688-040D82BF-B3E3-4D68-9F29-B852390FCD81Q43118355-74C7E4EC-058E-4657-B17F-DC37CD357F58
P2860
Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Viral-mediated gene therapy fo ...... imitations and recent advances
@ast
Viral-mediated gene therapy fo ...... imitations and recent advances
@en
type
label
Viral-mediated gene therapy fo ...... imitations and recent advances
@ast
Viral-mediated gene therapy fo ...... imitations and recent advances
@en
prefLabel
Viral-mediated gene therapy fo ...... imitations and recent advances
@ast
Viral-mediated gene therapy fo ...... imitations and recent advances
@en
P2860
P1476
Viral-mediated gene therapy fo ...... imitations and recent advances
@en
P2093
Guy L Odom
Jeffrey S Chamberlain
P2860
P304
P356
10.1016/J.BBADIS.2006.09.007
P407
P50
P577
2006-09-26T00:00:00Z